{"title":"Features of Maturation of Dendritic Cells from Monocytes Depending on HER2 Status of Breast Cancer.","authors":"A S Golderova, I E Nikolaeva","doi":"10.1007/s10517-025-06434-7","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, we analyzed the features of maturation of dendritic cell depending on the HER2 status of breast cancer based on morphology and immunophenotyping. Monocytes were isolated from the venous blood of 12 women with breast cancer: 4 patients with HER2<sup>-</sup> status and 8 with HER2<sup>+</sup> status. In patients with HER2<sup>-</sup> status, significantly lower (p = 0.029) expression of costimulatory membrane signal CD86 on dendritic cells on day 9 of culturing and reduced (p = 0.03) number of stretched cells on day 2 of culturing were revealed. Additionally, a correlation (r = 510; p = 0.031) was found between HER2<sup>+</sup> status and the number of round immature cells on day 7 of culturing. The results indicate that maturation of dendritic cells from peripheral blood monocytes from HER2<sup>+</sup> status breast cancer patients is less active and incomplete on the first and last days in culture compared to cells from HER2<sup>-</sup> patients. Low expression of CD86 costimulatory signal can be the cause of impaired antigen-presenting function of dendritic cells, which indirectly confirms aggressiveness of HER2<sup>+</sup> breast cancer.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"78-80"},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06434-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
In this study, we analyzed the features of maturation of dendritic cell depending on the HER2 status of breast cancer based on morphology and immunophenotyping. Monocytes were isolated from the venous blood of 12 women with breast cancer: 4 patients with HER2- status and 8 with HER2+ status. In patients with HER2- status, significantly lower (p = 0.029) expression of costimulatory membrane signal CD86 on dendritic cells on day 9 of culturing and reduced (p = 0.03) number of stretched cells on day 2 of culturing were revealed. Additionally, a correlation (r = 510; p = 0.031) was found between HER2+ status and the number of round immature cells on day 7 of culturing. The results indicate that maturation of dendritic cells from peripheral blood monocytes from HER2+ status breast cancer patients is less active and incomplete on the first and last days in culture compared to cells from HER2- patients. Low expression of CD86 costimulatory signal can be the cause of impaired antigen-presenting function of dendritic cells, which indirectly confirms aggressiveness of HER2+ breast cancer.
期刊介绍:
Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.
World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.
The Russian Volume Year is published in English from April.